Jason Buehler
Overview
Explore the profile of Jason Buehler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pehrson A, Onar G, Vance M, White W, Buehler J
Am J Med Qual
. 2023 Nov;
38(6):320-321.
PMID: 37908036
No abstract available.
2.
Zarrella K, Longmire P, Zeltzer S, Collins-McMillen D, Hancock M, Buehler J, et al.
PLoS Pathog
. 2023 Jun;
19(6):e1011185.
PMID: 37289831
Innate immune responses are crucial for limiting virus infection. However, viruses often hijack our best defenses for viral objectives. Human Cytomegalovirus (HCMV) is a beta herpesvirus which establishes a life-long...
3.
Zarrella K, Longmire P, Zeltzer S, Collins-McMillen D, Hancock M, Buehler J, et al.
bioRxiv
. 2023 Feb;
PMID: 36798153
Importance: Human cytomegalovirus (HCMV) is one of nine herpesviruses that infect humans. Following a primary infection, HCMV establishes a life-long latent infection that is marked by sporadic, and likely frequent...
4.
Pehrson A, Solla C, Buehler J, Vance M
J Public Health Policy
. 2023 Jan;
44(1):102-109.
PMID: 36624270
Abuse of physician prescribed opioids contributes to health and economic burdens associated with dependency, overdose, and death. Since the 1900s, the United States (U.S.) Congress has legislated use and misuse...
5.
Solla C, Pehrson A, Gulsah O, Indranoi T, Montgomery M, Buehler J
Pain Manag
. 2022 Aug;
12(7):821-827.
PMID: 36017724
At our institution, reductions to hydromorphone and fentanyl unit dose quantities provided us with a unique opportunity to study opioid utilization. A retrospective study examining effects of changes in opioid...
6.
Brown S, McLoughlin J, Russ A, Casillas M, Buehler J, Heidel R, et al.
Surg Endosc
. 2022 Jan;
36(8):6129-6137.
PMID: 35043232
Background: Post-operative ileus and delayed return of gastrointestinal function are complications seen frequently in patients undergoing colorectal surgery. Many enhanced recovery after surgery protocols include alvimopan to inhibit the effects...
7.
Vandergaast R, Carey T, Reiter S, Lathrum C, Lech P, Gnanadurai C, et al.
mSphere
. 2021 Jun;
6(3):e0017021.
PMID: 34077262
Neutralizing antibodies are key determinants of protection from future infection, yet well-validated high-throughput assays for measuring titers of SARS-CoV-2-neutralizing antibodies are not generally available. Here, we describe the development and...
8.
Peppenelli M, Buehler J, Goodrum F
Methods Mol Biol
. 2021 Feb;
2244:83-101.
PMID: 33555583
Of the many research challenges posed by the study of human cytomegalovirus (HCMV) latency, one of the most notable is the requirement for the use of primary hematopoietic cell culture....
9.
Vandergaast R, Carey T, Reiter S, Lech P, Gnanadurai C, Tesfay M, et al.
bioRxiv
. 2020 Jun;
PMID: 32577655
We here describe the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection. The test...
10.
Rak M, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S, et al.
J Virol
. 2020 Mar;
94(7).
PMID: 32184335
No abstract available.